Atopica for Dogs is a prescription medication specifically indicated for the control of atopic dermatitis in dogs. It contains cyclosporine USP Modified, an immunomodulating medication that targets the immune response involved in allergic skin inflammation.
Canine atopic dermatitis is a chronic allergic skin condition that can cause persistent itching, inflammation, and skin lesions. Atopica works at the source of the inflammatory response to help relieve itching and reduce skin lesions while providing an option for long-term management.
Atopica is intended for dogs at least 6 months of age and weighing at least 4 lb. Treatment begins with daily administration and may later be reduced to every-other-day or twice-weekly dosing when adequate control is maintained.
Atopica contains cyclosporine USP Modified, a systemic immunomodulating medication.
Cyclosporine inhibits activation of immune cells involved in the allergic inflammatory response. By modifying T-cell activity and associated inflammatory signaling, cyclosporine helps reduce the inflammation, itching, and skin lesions associated with canine atopic dermatitis.
Unlike corticosteroids, cyclosporine does not work through glucocorticoid activity and provides an alternative approach for long-term management of canine atopic dermatitis.
For use in dogs at least 6 months of age and weighing at least 4 lb for the control of:
Active Ingredients:
Inactive Ingredients:
Refer to manufacturer label for complete inactive ingredient information.Atopica is supplied as a liquid-filled soft gelatin capsule
Administer orally exactly as prescribed by your veterinarian.
Atopica should be administered:
Capsules should be swallowed intact. Do not break or open the capsules. Wear gloves during administration and wash hands afterward.
Weight / Dosage
The initial recommended dose is approximately 5 mg/kg once daily.
Initial Treatment
Maintenance Treatment
Following the initial daily treatment period, dosing frequency may be reduced to:
Reduce dosing frequency until the minimum frequency that maintains the desired therapeutic effect is reached.
Manufacturer Weight-Based Dosing
Administer exactly as prescribed by your veterinarian. Follow all dosing and administration instructions provided on the prescription label and by your veterinarian. Do not adjust the dose, frequency, route, or duration of administration unless directed by your veterinarian.
The most commonly reported adverse effects associated with Atopica are:
Other possible side effects may include:
Gastrointestinal effects and gingival hyperplasia may occur, particularly during initial treatment.
Because cyclosporine affects immune function, treatment may increase susceptibility to infection and development of neoplasia. Contact your veterinarian if your dog develops persistent vomiting or diarrhea, significant appetite changes, unusual weakness, signs of infection, abnormal growths, or another unexpected or concerning reaction.
Store and dispense Atopica in the original unit-dose container at controlled room temperature between 59°F and 77°F (15°C to 25°C). Keep the medication out of reach of children and animals.
Disposal
Dispose of unused or expired medication according to your veterinarian's, pharmacist's, or local medication disposal recommendations.
Do not open capsules before disposal. Do not give unused medication to another animal. Keep discarded medication and packaging where children and animals cannot access them.